2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow gremubamab: new trials by email Literature Review of gremubamab trials Research Report on gremubamab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects MEDI3902, Placebo - Pseudomonas Aeruginosa | Phase 2 | Completed | MedImmune LLC | 188 | 2016-03-25 | 2021-02-04 |
| Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults MEDI3902 - Dose 1, MEDI3902 - Dose 2, MEDI3902 - Dose 3 - MEDI3902 for Prevention of P. Aeruginosa Pneumonia | Phase 1 | Completed | MedImmune LLC | 56 | 2014-09-04 | 2018-08-13 |
Pneumonia (1) · Pseudomonas Infections (1)
MedImmune LLC (2)
United States (2) · Austria (1) · Belgium (1) · Croatia (1) · Czechia (1) · France (1) · Greece (1) · Hungary (1) · Ireland (1) · Israel (1) · Portugal (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Hasan S. Jafri, M.D. (1) · Martha Hernandez-Illas, MD (1)